Abbassi M - Search Results

1

Effective and Safe Daclatasvir Drug Exposures Predicted in Children Using Adult Formulations.

Cressey TR, Abbassi M, Lallemant M, Indolfi G, Al-Nahari M, Farid S, Penazzato M, Easterbrook P, El-Sayed MH. Cressey TR, et al. Among authors: abbassi m. Pediatr Infect Dis J. 2021 Dec 1;40(12):1081-1086. doi: 10.1097/INF.0000000000003282. Pediatr Infect Dis J. 2021. PMID: 34321444

2

Randomized comparative efficacy and safety study of intermittent simvastatin versus fenofibrate in hemodialysis.

Abdel Magid AM, Abbassi MM, Iskander EEM, Mohamady O, Farid SF. Abdel Magid AM, et al. Among authors: abbassi mm. J Comp Eff Res. 2017 Jul;6(5):413-424. doi: 10.2217/cer-2016-0076. Epub 2017 Jun 19. J Comp Eff Res. 2017. PMID: 28627930 Free article. Clinical Trial.

3

Pharmacokinetics of daclatasvir in Egyptian adolescents with genotype-4 HCV infection.

Al-Nahari MM, Abbassi MM, Ebeid FS, Hassany M, El-Sayed MH, Farid SF. Al-Nahari MM, et al. Among authors: abbassi mm. Antivir Ther. 2020;25(2):101-110. doi: 10.3851/IMP3357. Antivir Ther. 2020. PMID: 32367815

4

The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial.

Abdel Monem MS, Farid SF, Abbassi MM, Youssry I, Andraues NG, Hassany M, Selim YMM, El-Sayed MH. Abdel Monem MS, et al. Among authors: abbassi mm. Int J Clin Pract. 2021 Jun;75(6):e14104. doi: 10.1111/ijcp.14104. Epub 2021 Mar 17. Int J Clin Pract. 2021. PMID: 33617679 Clinical Trial.

5

Awareness of the Egyptian public about COVID-19: what we do and do not know.

Sabry N, ElHadidi S, Kamel A, Abbassi M, Farid S. Sabry N, et al. Among authors: abbassi m. Inform Health Soc Care. 2021 Sep 2;46(3):244-255. doi: 10.1080/17538157.2021.1883029. Epub 2021 Feb 23. Inform Health Soc Care. 2021. PMID: 33622157

6

The EQ-5D-5L Valuation Study in Egypt.

Al Shabasy SA, Abbassi MM, Finch AP, Baines D, Farid SF. Al Shabasy SA, et al. Among authors: abbassi mm. Pharmacoeconomics. 2021 May;39(5):549-561. doi: 10.1007/s40273-021-01002-z. Epub 2021 Mar 12. Pharmacoeconomics. 2021. Retraction in: Pharmacoeconomics. 2021 Aug;39(8):971. doi: 10.1007/s40273-021-01055-0 PMID: 33709283 Free PMC article. Retracted.

7

Retraction Note to: The EQ-5D-5L Valuation Study in Egypt.

Al Shabasy SA, Abbassi MM, Finch AP, Baines D, Farid SF. Al Shabasy SA, et al. Among authors: abbassi mm. Pharmacoeconomics. 2021 Aug;39(8):971. doi: 10.1007/s40273-021-01055-0. Pharmacoeconomics. 2021. PMID: 34129227 Free PMC article. No abstract available.

8

Beta-thalassemia major alters sofosbuvir/ledipasvir exposure in Hepatitis C virus infected adolescent patients.

El-Baraky IA, Abbassi MM, Ebeid FS, Hassany M, Sabry NA, El-Sayed MH. El-Baraky IA, et al. Among authors: abbassi mm. Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101747. doi: 10.1016/j.clinre.2021.101747. Epub 2021 Jun 26. Clin Res Hepatol Gastroenterol. 2021. PMID: 34186262

9

The EQ-5D-5L Valuation Study in Egypt.

Al Shabasy S, Abbassi M, Finch A, Roudijk B, Baines D, Farid S. Al Shabasy S, et al. Among authors: abbassi m. Pharmacoeconomics. 2022 Apr;40(4):433-447. doi: 10.1007/s40273-021-01100-y. Epub 2021 Nov 17. Pharmacoeconomics. 2022. PMID: 34786590 Free PMC article.

10

EQ-VT protocol: one-size-fits-all? Challenges and innovative adaptations used in Egypt: a cross-sectional study.

Al Shabasy S, Abbassi M, Farid S. Al Shabasy S, et al. Among authors: abbassi m. BMJ Open. 2021 Dec 23;11(12):e051727. doi: 10.1136/bmjopen-2021-051727. BMJ Open. 2021. PMID: 34949616 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters